Taysha Gene Therapies, Inc. Earnings Per Share, Basic and Diluted
Taysha Gene Therapies, Inc. (TSHA) reported Earnings Per Share, Basic and Diluted of -$1.31 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-16
- Taysha Gene Therapies, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$1.31.
- Taysha Gene Therapies, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$1.32.
- Taysha Gene Therapies, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$1.35.
- Taysha Gene Therapies, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$1.09.
- Taysha Gene Therapies, Inc. earnings per share, basic and diluted for fiscal 2021 was -$4.64.
- Taysha Gene Therapies, Inc. earnings per share, basic and diluted for fiscal 2020 was -$3.40.
| Period end | Earnings Per Share, Basic and Diluted 0 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | -$1.31 10-Q · filed 2022-05-16 | -$2.64 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$3.99 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$5.08 derived: net income ÷ weighted average shares · filed 2023-05-11 | |
| 2021-12-31 | -$1.32 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$2.67 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$3.76 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$4.64 10-K · filed 2022-03-31 | |
| 2021-09-30 | -$1.35 10-Q · filed 2021-11-10 | -$2.44 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$3.31 10-Q · filed 2021-11-10 | -$3.81 derived: net income ÷ weighted average shares · filed 2022-11-08 | |
| 2021-06-30 | -$1.09 10-Q · filed 2021-08-16 | -$1.96 10-Q · filed 2021-08-16 | -$2.45 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$3.45 derived: net income ÷ weighted average shares · filed 2022-08-11 | |
| 2021-03-31 | -$0.87 10-Q · filed 2022-05-16 | -$1.36 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$2.28 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$3.58 derived: net income ÷ weighted average shares · filed 2022-05-16 | |
| 2020-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$1.37 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$2.74 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$3.40 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$1.28 10-Q · filed 2021-11-10 | -$3.21 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$3.73 10-Q · filed 2021-11-10 | -$3.97 derived: net income ÷ weighted average shares · filed 2021-11-10 | |
| 2020-06-30 | -$1.95 10-Q · filed 2021-08-16 | -$2.45 10-Q · filed 2021-08-16 | -$2.65 derived: net income ÷ weighted average shares · filed 2021-08-16 | ||
| 2020-03-31 | -$0.50 10-Q · filed 2021-05-11 | -$0.64 derived: net income ÷ weighted average shares · filed 2021-05-11 | |||
| 2019-12-31 | -$0.12 10-K · filed 2021-03-03 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |